Endothelial specific targeting
AssigneeUniversity of Pittsburgh
InventorsMichael K. Wong, Ruth A. Modzelewski, Charles Komen Brown, Candace S. Johnson, Donald L. Trump
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Pittsburgh
InventorsMichael K. Wong, Ruth A. Modzelewski, Charles Komen Brown, Candace S. Johnson, Donald L. Trump
Estimating the term…
Peptide motifs which define specificity of tumor-derived endothelial cells. These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium. The specific molecular peptide motifs will facilitate diverse therapeutic and diagnostic applications including: anti-angiogenic therapies to be used in alone or in conjunction with standard therapies; imaging tools for both detection of very small metastasis that are undetectable by current techniques; for monitoring tumor response; for targeting and directing chemotherapy drugs to the tumor; for treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis, for treating some forms of blindness; as well as other diagnostic and therapeutic applications.
A purified peptide fragment with selective binding to tumor-derived endothelial cells, wherein the peptide fragment possesses a charge motif of positive- positive- neutral hydrophobic (++).
A composition useful for targeting tumor-derived endothelial cells, said composition comprising a peptide selected from the group consisting essentially of SEQ ID NO 1 Cys-Gly-Gly-Arg-His-Ser-Gly-Gly-Cys;
A method for treating a diseased state in a mammal comprising:
Dependencies are inferred from the claim text.